MedTrace Logo

Lung Transplantation for Pleuroparenchymal Fibroelastosis

NCT05044390 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-09-14

No results posted yet for this study

Summary

This retrospective observational study will evaluate the outcomes of lung transplantation for a rare cause of interstitial lung disease called pleuroparenchymal fibroelastosis. Data will be collected from all transplantation center in France.

Conditions

  • Fibroelastosis

Interventions

PROCEDURE

Lung transplantation (single, lobar or bilateral lung transplantation)

Lung transplantation were performed for end-stage interstitial lung disease secondary to pleuroparenchymal fibroelastosis

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-07-01
Completion
2021-11-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05044390 on ClinicalTrials.gov